Skip to content
TrialScanner

NCT02089113

OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

Phase 3CompletedOCULLead

Registry record

Lead sponsor
Ocular Therapeutix, Inc.
Conditions
Post-Surgical Ocular Pain; Post-Surgical Ocular Inflammation
Primary completion
Jan 2015Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02089113 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02089113: OTX-14-003: A Phase 3 Study... | TrialScanner